Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs
- 16 November 2005
- Vol. 23 (46-47), 5424-5431
- https://doi.org/10.1016/j.vaccine.2005.02.028
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ten year follow-up of healthy children who received one or two injections of varicella vaccineThe Pediatric Infectious Disease Journal, 2004
- Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine ResearchClinical Microbiology Reviews, 2003
- Valaciclovir for the Suppression of Recurrent Genital Herpes Simplex Virus Infection: A Large‐Scale Dose Range‐Finding StudyThe Journal of Infectious Diseases, 1998
- A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 DiseaseThe Journal of Infectious Diseases, 1997
- Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1The Journal of Infectious Diseases, 1994
- Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.Journal of Clinical Investigation, 1993
- In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in RodentsThe Journal of Infectious Diseases, 1988
- Infections with Herpes Simplex VirusesNew England Journal of Medicine, 1986
- Genital Herpes in Guinea Pigs: Pathogenesis of the Primary Infection and Description of Recurrent DiseaseThe Journal of Infectious Diseases, 1982
- Herpesvirus hominis Infection in Newborn Mice. I. An Experimental Model and Therapy with IododeoxyuridineThe Journal of Infectious Diseases, 1973